Business

Christian Carlsen, Business Director of NNE, showcases the diverse Danish ecosystem and explains how NNE is striving to accomplish its mission of adding value to the medical cannabis industry.

Denmark proudly supports its healthcare services, showcasing a long history of life science, further coupled with valuable experience in agriculture and horticulture. Now, with a rapidly evolving medical cannabis industry, Denmark has the opportunity to cohesively align its progressing ecosystem to work together with diverse companies emerging in the medical cannabis marketplace.

Canadian cannabis company is expecting to make first shipments to the EU by the end of May

Aphria Inc.’s U.S.-listed shares rose about 3% Tuesday, after news that the company has achieved GMP status in the European Union, clearing the path for it to start selling medical cannabis to pharmacies in Germany and other countries.

• The U.S. cannabis market is quickly developing with medical marijuana currently legal in 33 states and recreational pot legal in 11 states.

• Our top picks are Curaleaf, Green Thumb, Trulieve, and Charlotte's Web based on management, footprint/scale, balance sheet, and profitability.

• We believe there are multiple ways of playing the U.S. cannabis sector but a prudent approach involves a basket of 3-5 stocks to reduce risk.

The U.S.

Small and mid-sized cannabis companies say they are finding it increasingly hard to obtain basic credit facilities from some of Canada’s largest financial institutions amid heightened scrutiny on the struggling sector.

“It seems that most charted banks do not want to entertain new applications for lines of credits, loans, or new bank accounts,” said Sam Rad, a marketing executive at CannaPiece Group Inc., a late-stage cannabis licence applicant.

Cannabis companies that got into the game earlier had more luck with the banks

Regulatory and tax reforms have been proposed to tip the scale in favor of legal cannabis operators.

Although 2019 began well for cannabis stocks and industry hopes were (pardon the pun) high, it ended in disaster.

The rollout of marijuana legalization in Illinois has been well covered by the press for the first few weeks of 2020, primarily due to the long lines and sky-high sales numbers the state has seen.

Cannabis Dispensary Stocks a Compelling Subgroup for Growth

Despite some analysts predicting that the legal cannabis market could eventually be worth $500.0 billion, we’re not quite there yet. The marijuana industry is still in its infancy and is experiencing growing pains.

One subcategory that has been performing exceptionally well—and is expected to continue doing so—is marijuana dispensary stocks.

More than 40 U.S. states could allow some form of legal marijuana by the end of 2020, including deep red Mississippi and South Dakota — and they’re doing it with the help of some conservatives.

State lawmakers are teeing up their bills as legislative sessions kick off around the country, and advocates pushing ballot measures are racing to collect and certify signatures to meet deadlines for getting their questions to voters.

New data suggests that cannabis stock pessimism may finally be waning.

In just one year, marijuana stocks went from being a cash machine for investors to a vacuum looking to suck their investment capital dry.